Brooklyn Investment Group’s AstraZeneca AZN Stock Holding History

Brooklyn Investment Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.83M	Sell	24,472 -33,979	-58%	-$6.55M	0.15%	97
2025 Q4	$10.8M	Buy	58,451 +43,619	+294%	+$7.65M	0.5%	28
2025 Q3	$2.07M	Buy	14,832 +62	+0.4%	+$9.38K	0.28%	66
2025 Q2	$2.06M	Buy	14,770 +7,416	+101%	+$1.04M	0.27%	67
2025 Q1	$1.08M	Buy	7,354 +6,466	+728%	+$936K	0.23%	82
2024 Q4	$116K	Buy	888 +862	+3,315%	+$121K	0.03%	342
2024 Q3	$4.05K	Buy	+26	New	+$4.2K	﹤0.01%	881

Other funds holding AZN

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Asset Management London, Ec4n 8af $148B AUM

Brooklyn Investment Group's AZN Position: Q1 2026 in Review

Brooklyn Investment Group reduced its AstraZeneca (AZN) stake by 58% in Q1 2026, selling an estimated $6.55M and leaving 24,472 shares worth $4.83M. The position accounts for 0.15% of the portfolio, ranked #97.

Brooklyn Investment Group first reported a position in AZN in Q3 2024 and has held it in 7 quarters since. The position peaked at $10.8M in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Brooklyn Investment Group held 24,472 shares of AstraZeneca worth $4.83M as of Q1 2026.
Brooklyn Investment Group sold 33,979 AstraZeneca shares in Q1 2026, an estimated $6.55M.
AstraZeneca made up 0.15% of Brooklyn Investment Group's portfolio in Q1 2026, its #97 holding.
Brooklyn Investment Group first reported a position in AstraZeneca in Q3 2024 and has held it in 7 quarters since.
Brooklyn Investment Group's AstraZeneca position peaked at $10.8M in Q4 2025.
1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.